SCM
STML

Stonepine Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Stonepine Capital Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-886,632
Closed -$4.29M – 27
2020
Q1 		$4.29M Buy
+886,632
New +$5.75M 4.54% 7

Stonepine Capital Management's STML Position: Q2 2020 in Review

Stonepine Capital Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 886,632 shares — an estimated $4.29M sold.

Stonepine Capital Management first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $4.29M in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Stonepine Capital Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Stonepine Capital Management sold 886,632 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $4.29M.
  • Stonepine Capital Management first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Stonepine Capital Management's Stemline Therapeutics, Inc. position peaked at $4.29M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Stonepine Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.